Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Michał BrzdękDorota Zarębska-MichalukKrzysztof TomasiewiczMagdalena Tudrujek-ZdunekBeata LorencWłodzimierz MazurHanna BerakJustyna Janocha-LitwinJakub KlapaczyńskiMarek SitkoEwa JanczewskaDorota DybowskaAnna Parfieniuk-KowerdaAnna PiekarskaJerzy JaroszewiczRobert FlisiakPublished in: Minerva medica (2024)
DAA-based therapies are highly effective and well tolerated by the elderly patients, including those over 85. Age should not be a barrier to treatment, but careful management is necessary.